62
Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Embed Size (px)

Citation preview

Page 1: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Dr. Mahmoud IsmailProfessor and Chief of Maternal Fetal

Medicine

University of Chicago

Department of Obstetrics & Gynecology

Intrauterine Growth Restriction

Page 2: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

• Definition• Types of IUGR• Etiology

– Feto placental– Maternal

• Diagnosis– Fetal Measurements– Oligohydramnios– Maternal Doppler Velocimetry

Page 3: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R

• Management– Antepartum

• Fetal Growth• Fetal Well Being• Therapy• Timing of Delivery

– Neonatal outcome• Immediate Morbidity• Long Term Morbidity

Page 4: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Definition

Failure of the fetus to reach growth potential associated with increased morbidity and mortality

Page 5: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Facts

• Perinatal mortality 120/1000• 2nd leading contributor to the Perinatal

mortality rate• 40% of all stillbirths are IUGR• Incidence of intrapartum asphyxia in cases of

IUGR has been reported to be 50%.• Early and proper identification and

management lowers this perinatal mortality and morbidity

Page 6: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Phases of fetal growth

First 16 weeks: mostly cellular hyperplasia

16-32 weeks: both hyperplasia and hypertrophy

>32 weeks: mostly hypertrophy

Thus: early growth restriction will affect cell numbers and have a global (symmetrical) effect. Later cell size will be affected.

Page 7: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Factors influencing intrauterine growth

Race (Pygmy=2.64kg Altitude

USA Amerindian=3.6kg)

Gender Multiple gestation

Smoking, alcohol Socioeconomic level

Pathology * Maternal

* Fetal (genetic disorders, infections)

* Placental

Page 8: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 9: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 10: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 11: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Fetal growth patterns (1)

Normal +/-2 SD

Abnormal > 2 SD

Page 12: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Fetal growth patterns (2)

Normal: AGA

constitutional

Decreased: SGA

pathology (IUGR)

Increased: LGA constitutional

pathology

Page 13: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Fetal growth patterns (3)

IUGR:

Intrinsic

(early, symmetric)

Extrinsic

(“metabolic”, late, asymmetric)

Page 14: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Mixed patterns:

Karyotypic anomaly in preeclampsia Long-standing placental insufficiency causes decrease in HC and even FL

Page 15: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Early I.U.G.R.

Triploidy and Tri 18: very early and severe.

Tri 13: less severe

Tri 21; no IUGR but short femur and humerus

Cardiac malformations

Early intrauterine infection: early SAB, IUFD

fetal hydrops, IUGR

Page 16: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Symmetric I.U.G.R.

1/3 of all cases

Fetus is proportionally small (HC, AC, FL)

Diagnosed early

Early insult affecting cell number (intrauterine infection, karyotype anomaly, genetic syndrome)

Page 17: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Asymmetric I.U.G.R.

“nutritional”

Placental insufficiency, late 2nd/3rd trimesters

Slow AC growth vs normal HC and FL

(glycogen utilization by liver, liver shrinkage, decreased AC; preferential shunting to brain thus maintained HC)

Page 18: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 19: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 20: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 21: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R. – diagnosis (2)

Ultrasound:

1. BPD, HC, AC, FL, transcerebellar distance, cheek-

to-cheek diameter, HC:AC ratio, FL:AC ratio, EFW.

2. Serial measurements (not less than 2 weeks interval)

3. Oligohydramnios

Page 22: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 3 This figure displays a decision tree following the evaluationof fetal anatomy, amniotic fluid volume, umbilical and middle cerebralartery Doppler. The most likely clinical diagnosis based onthe test results is presented on the right hand side. A high index ofsuspicion for aneuploidy, viral, and nonaneuploid syndrome needsto be maintained at all times. (Reproduced with permission: BaschatA: Intrauterine growth restriction, in Gabbe SG (ed): Obstetrics:Normal and Problem Pregnancies (ed 5). Philadelphia, PA,Churchill Livingstone, 2007, pp 771-814.)

Page 23: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R. – clinical significance

Increased Perinatal morbidity and mortality (x10)

Fetal distress, stillbirth, neonatal hypoglycemia, polycythemia, meconium aspiration, hypocalcemia

Page 24: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 25: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 26: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Management

Antepartum fetal testing

• BPD

• Doppler ultrasound assessment of fetal blood flow

• Venous circulation

• Cordocentesis

Page 27: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Early IUGR - evaluation

Detailed ultrasound

Amniocentesis (karyotyping, TORCH)

Follow-up every 2 weeks

Antenatal testing at viability (kick count, AFV, NST, BPP, Doppler studies)

Page 28: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R. - surveillance

Fetal kick count

NST

AFI

Biophysical profile (+ modified BPP)

Doppler

Page 29: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Dev Maulik, Management of Fetal Growth Restriction: An Evidence Based ApproachClinical Obstetrics and Gynecology, Vol 49, June 2006

Page 30: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Antepartum Therapy• Maternal hyperoxia (Nicolaides et al

1987) (Battraglia et al 1992)• Low dose aspirin

Leitich et al 1997: Meta analysis of 13 randomized studies 13, 234 women decrease I.U.G.R. and pre-eclampsia

Brazilian report (ECPPA 1996): no ameliorating effect on I.U.G.R.

Page 31: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Management

Timing of delivery• Fetal lungs maternity achieved• Absence or reverse end diastolic flow velocity of

umbilical artery wave-form (Karsdorp 1994, Valacmonico et al 1994)

• In case of preterm I.U.G.R. decision should be based on maternal health, fetal function tests, biochemical test of fetal lung maturity

Page 32: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.The role of Doppler (1)

Umbilical artery

Uterine artery

Middle cerebral artery

Ductus venosus

Page 33: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.The role of Doppler (2)

Umbilical a: association between high resistance and IUGR (Trudinger, 1985) and placental histology (Voigt, 1992)

Normal: S/D=4 @ 20 w., 3 @ 30 w., 2 @ 40 w.

Page 34: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 35: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.The role of Doppler (3)

Umbilical a: progression is from normal end-diastolic velocity (EDV) to decreased, to absent to reverse EDV.

PPV in precipitating antenatal asphyxia = 92% (Donner, 1995)

Precedes FHR anomalies by 3 days

Page 36: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 2 The normal umbilical artery flow velocity waveform has marked positive end-diastolic velocity that increasesin proportion to systole toward term (A). Moderate abnormalities in the villous vascular structure raise the blood flowresistance and are associated with a decline in end-diastolic velocities (B). When a significant proportion of the villousvascular tree is abnormal (50-70%), end-diastolic velocities may be absent (C) or even reversed (D). Depending on themagnitude of placental blood flow resistance and the fetal cardiac function, reversal of end-diastolic velocities may beminimal (D), moderate (E), or severe (F). In the latter case precordial venous flows were universally abnormal.(Reprinted with permission.36)

Page 37: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R The role of Doppler (4)

Uterine a. :by 20 weeks, low-impedance waveform and no diastolic notch. If still high impedance and diastolic notch, high risk of IUGR and/or preeclampsia. As screening test, 82% sensitivity, 38% specificity (Bewley, 1991)

Value in high-risk patients only.

Page 38: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 1 Flow velocity waveforms obtained from the uterine arterybeyond 24 weeks gestation. In the first patient (A) high-volumediastolic flow is established, indicating successful trophoblast invasion. Elevated placental vascular resistance is associated with a decline in diastolic velocities and a subsequent rise in the Dopplerindex (B). Persistence of an early diastolic notch in the uterine arteryflow velocity waveform is evidence of increased spiral artery bloodflow resistance. Frequently “notching” is more subtle beyond 32weeks (C) than in the late second or early third trimesters(D). (Reprinted with permission.36)

Page 39: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.RThe role of Doppler (5)

Middle cerebral a. (MCA) : resistance and velocity (blood redistribution, brain sparing). Late: resistance, ? Due to cerebral edema (Hecher, 1995)

Indices: velocity (angle dependent), PI, RI.

PI=2 @ 20w, 2 @ 30w., 1.5 @ 36 w, 1.25 @ 40 w

Fetal Thoracic aorta:

Normal: PI=1.8 2.2 from 20 to 40 weeks

In IUGR, increased resistance

Page 40: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 3 The normal middle cerebral artery flow pattern has relativelylittle diastolic flow (A). With elevation of placental blood flowresistance the changes in the middle cerebral artery waveform maybe subtle, although the cerebroplacental ratio may become abnormalas in fetus B. With progressive placental dysfunction there maybe an increase in the diastolic velocity, resulting in a decrease in theDoppler index (Brain sparing, C).With marked brain sparing, thesystolic down slope of the waveform becomes smoother so thatthe waveform almost resembles that of the umbilical artery (D). Theassociated rise in the mean velocity results in a marked decline in theDoppler index. (Reprinted with permission.36)

Page 41: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 42: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 43: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

IUGRThe role of Doppler (6)

Ductus venosus: normal is forward flow during atrial contraction. IUGR causes peripheral resistance and eventually rt heart failure with no forward flow. When back pressure reaches umbilical vein, normally minimally pulsatile waveform becomes pulsatile as sign of imminent demise.

Abnormal values associated with 8.2 RR, and pulsations with 18 RR of Perinatal mortality (Gramellini, 2001)

Page 44: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 4 In the ductus venosus blood flow is always antegrade throughout the cardiac cycle under normal circumstances. Pulsatility is less pronounced in waveform patterns obtained at the inlet (A) versus the outlet (B). With impaired cardiac forward function there is a decline in forward flow during atrial systole (C). If progressive atrial forward flow may be lost (D) or reversed (E, F). (Reprinted with permission.36)

Page 45: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

I.U.G.R.

Management

Intrapartum• Adequate oxygenation• Continuous fetal monitor with scalp

electrode• Cesarean section for deteriorating fetal

condition, uncomfortable cervix• OB- Ped Team approach to decrease of

meconium aspiration

Page 46: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 47: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V.

• S.V. is a 33 y.o. G3P0030 African American female with di/di twin gestation at 25 weeks who presents to genetic counseling due significant growth discordance.

• PMHx: 2 unexplained SAB’s• FMHx: noncontributory• U/S shows 53% discordance

– Twin A – 3 weeks behind with hyperechoic bowel, oligohydramnios, and AEDV

– Twin B – appropriate growth, polyhydramnios

Page 48: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 11/7/02

Page 49: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 11/7/02

Page 50: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 11/7/02

Page 51: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 11/7/02

Page 52: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 12/2/02

Page 53: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 12/2/02

Page 54: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V. – 12/2/02

Page 55: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

S.V.

• Follow-up U/S showed 69% discordance with significant MCA redistribution, as low as PI 0.8

• Genetic counseling offered… patient declined genetic amniocentesis for Twin A

• Patient admitted for PPROM on 12/4/02 and subsequently delivered 12/6/02

Page 56: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Baschat et. Al Seminars in Perinatology, Vol 28, 2004

Page 57: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 58: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Barker Hypothesis

• Barker and colleagues at the United Kingdom Medical Research Unit have found evidence that suggests an association between suboptimal fetal nutrition and an increased risk for hypertension and atherosclerosis in later life.

Page 59: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 1 This figure displays a diagramatic representation of pHdeviation from the gestational age

mean (pH) with abnormal testresults in various antenatal tests.

These include fetal heart rate(FHR) analysis using traditional nonstress testing (NST; –react,

nonreactive)and the computerized

cardiotocogram (cCTG; acc, accelerations

present; dec, obvious decelerations present; STV,

short-term variation). Biophysical variables (AFV, amniotic fluid

volume; FBM, fetal body movement; FGM, fetal gross movement).The same relationships are

expressed for umbilical artery absent

end-diastolic velocity (AEDV) and deviation of the arterial or venous

Doppler index2 SD from the gestational age mean for the

thoracicaorta (TAO), descending aorta

(DAO), the middle cerebral artery(MCA), cerebroplacental ratio

(CPR), and the ductus venosus (DV).

The median pH values for abnormal BPS and Doppler findings are

indicated by bars.

Page 60: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction

Figure 4 The management algorithm for pregnancies complicated by FGR is based on the ability to perform arterial andvenous Doppler as well as a full five-component biophysical profile score. This is the typical management approach wepractice at the University of Maryland, Baltimore for preterm growth restricted fetuses (unless otherwise indicated).Max, maximum; A/REDV, absent/reversed end-diastolic velocity; BPS, biophysical profile score; DV, ductus venosus;MCA, middle cerebral artery; NICU, neonatal intensive care unit; UA, umbilical artery.

Page 61: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction
Page 62: Dr. Mahmoud Ismail Professor and Chief of Maternal Fetal Medicine University of Chicago Department of Obstetrics & Gynecology Intrauterine Growth Restriction